Skip to main content
Top
Published in: Pituitary 4/2012

01-12-2012

Pituitary immunoexpression of ghrelin in anorexia nervosa

Authors: Fabio Rotondo, Bernd W. Scheithauer, Luis V. Syro, Angelo Rotondo, Kalman Kovacs

Published in: Pituitary | Issue 4/2012

Login to get access

Abstract

Ghrelin, an orexigenic hormone, is known to occur in the normal anterior pituitary where its physiologic role is uncertain but may include promotion of appetite. We sought to investigate anticipated differences in adenohypophysial and neurohypophysial ghrelin immunoexpression between normal subjects and patients with anorexia nervosa who had succumbed to complications of the disease. We hypothesized that the glands of anorexia nervosa patients would show relative diminished action in ghrelin content. The study included 12 autopsy-derived pituitaries of anorexia nervosa and 10 control glands. The streptavidin-biotin-peroxidase complex method and double immunohistochemical staining method were used to determine which cell types expressed both ghrelin and adenohypophysial hormones. Nontumorous control pituitaries were also obtained at autopsy. In anorexia nervosa and control adenohypophyses, ghrelin was mainly localized in somatotrophs and to a lesser extent in corticotrophs and gonadotrophs. Ghrelin accumulated within nerve fibers and Herring bodies in the neurohypophysis and pituitary stalk. In the controls, ghrelin expression was apparent in only a few cases. It was mild and only along few nerve fibers. In the adenohypophyses of anorexia nervosa patients, ghrelin was not depleted. It appears that in these patients, ghrelin is transported in excess from the hypothalamic neurohypophysial tract to the neurohypophysis.
Literature
1.
go back to reference Walsh BT (2008) Eating disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine, 17th edn. McGraw-Hill Medical, New York Walsh BT (2008) Eating disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine, 17th edn. McGraw-Hill Medical, New York
2.
go back to reference Nogal P, Pniewska-Siark B, Lewiński A (2008) Evaluation of selected clinical and diagnostic parameters in girls with anorexia nervosa (I). Neuro Endocrinol Lett 29:421–427PubMed Nogal P, Pniewska-Siark B, Lewiński A (2008) Evaluation of selected clinical and diagnostic parameters in girls with anorexia nervosa (I). Neuro Endocrinol Lett 29:421–427PubMed
3.
go back to reference Himmerich H, Schönknecht P, Heitmann S, Sheldrick AJ (2010) Laboratory parameters and appetite regulators in patients with anorexia nervosa. J Psychiatr Pract 16:82–92PubMedCrossRef Himmerich H, Schönknecht P, Heitmann S, Sheldrick AJ (2010) Laboratory parameters and appetite regulators in patients with anorexia nervosa. J Psychiatr Pract 16:82–92PubMedCrossRef
4.
go back to reference Hoek HW, van Hoeken D (2003) Review of the prevalence and incidence of eating disorders. Int J Eat Disord 34:383–396PubMedCrossRef Hoek HW, van Hoeken D (2003) Review of the prevalence and incidence of eating disorders. Int J Eat Disord 34:383–396PubMedCrossRef
5.
go back to reference Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB (2003) Predictors of mortality in eating disorders. Arch Gen Psychiatry 60:179–183PubMedCrossRef Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB (2003) Predictors of mortality in eating disorders. Arch Gen Psychiatry 60:179–183PubMedCrossRef
6.
go back to reference Birmingham CL, Su J, Hlynsky JA, Goldner EM, Gao M (2005) The mortality rate from anorexia nervosa. Int J Eat Disord 38:143–146PubMedCrossRef Birmingham CL, Su J, Hlynsky JA, Goldner EM, Gao M (2005) The mortality rate from anorexia nervosa. Int J Eat Disord 38:143–146PubMedCrossRef
7.
go back to reference Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE (2009) Effect of ghrelin on gonadotrophin secretion in women during the menstral cycle. Hum Pathol 24:976–981 Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE (2009) Effect of ghrelin on gonadotrophin secretion in women during the menstral cycle. Hum Pathol 24:976–981
8.
go back to reference Lawson EA, Klibanski A (2008) Endocrine abnormalities in anorexia nervosa. Nat Clin Pract Endocrinol Metab 4:407–414PubMedCrossRef Lawson EA, Klibanski A (2008) Endocrine abnormalities in anorexia nervosa. Nat Clin Pract Endocrinol Metab 4:407–414PubMedCrossRef
9.
go back to reference Kluge M, Biedl S, Uhr M, Schmidt D, Zhang X, Yassouridis A, Steiger A (2010) Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol 162:1059–1065PubMedCrossRef Kluge M, Biedl S, Uhr M, Schmidt D, Zhang X, Yassouridis A, Steiger A (2010) Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol 162:1059–1065PubMedCrossRef
10.
go back to reference Broglio F, Gottero C, Arvat E, Ghigo E (2003) Endocrine and non-endocrine actions of ghrelin. Horm Res 59:109–117PubMedCrossRef Broglio F, Gottero C, Arvat E, Ghigo E (2003) Endocrine and non-endocrine actions of ghrelin. Horm Res 59:109–117PubMedCrossRef
11.
go back to reference Tolle V, Kadem M, Bluet-Pajot MT, Frere D, Foulon C, Bossu C, Dardennes R, Mounier C, Zizzri P, Lang F, Epelbaum J, Estour B (2003) Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 88:109–116PubMedCrossRef Tolle V, Kadem M, Bluet-Pajot MT, Frere D, Foulon C, Bossu C, Dardennes R, Mounier C, Zizzri P, Lang F, Epelbaum J, Estour B (2003) Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 88:109–116PubMedCrossRef
12.
go back to reference Støving RK, Chen JW, Glintborg D, Brixen K, Flyvbjerg A, Hørder K, Frystyk J (2007) Bioactive insulin-like growth factor (IGF) 1 and IGF-binding protein-1 in anorexia nervosa. J Clin Endocrinol Metab 92:2323–2329PubMedCrossRef Støving RK, Chen JW, Glintborg D, Brixen K, Flyvbjerg A, Hørder K, Frystyk J (2007) Bioactive insulin-like growth factor (IGF) 1 and IGF-binding protein-1 in anorexia nervosa. J Clin Endocrinol Metab 92:2323–2329PubMedCrossRef
13.
go back to reference Misra M, Klibanski A (2010) Neuroendocrine consequences of anorexia nervosa in adolescents. Endocr Dev 17:197–214PubMedCrossRef Misra M, Klibanski A (2010) Neuroendocrine consequences of anorexia nervosa in adolescents. Endocr Dev 17:197–214PubMedCrossRef
14.
go back to reference Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660PubMedCrossRef Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660PubMedCrossRef
15.
go back to reference Tomasetto C, Karam SM, Ribieras S, Masson R, Lefèbvre O, Staub A, Alexander G, Chenard MP, Rio MC (2000) Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 119:395–405PubMedCrossRef Tomasetto C, Karam SM, Ribieras S, Masson R, Lefèbvre O, Staub A, Alexander G, Chenard MP, Rio MC (2000) Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 119:395–405PubMedCrossRef
16.
go back to reference Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, kojima M, Kangawa K, Dieguez C, Casanueva F (2001) Ghrelin, a novel placental-derived hormone. Endocrinology 142:788–794PubMedCrossRef Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, kojima M, Kangawa K, Dieguez C, Casanueva F (2001) Ghrelin, a novel placental-derived hormone. Endocrinology 142:788–794PubMedCrossRef
17.
go back to reference Mori K, Yoshimoto A, Takaya K, Hosoda K, Ariyasi H, Yahata K, Mukoyama M, Sugawara A, Hosoda H, Kojima M, Kangawa K, Nakao K (2000) Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 486:213–216PubMedCrossRef Mori K, Yoshimoto A, Takaya K, Hosoda K, Ariyasi H, Yahata K, Mukoyama M, Sugawara A, Hosoda H, Kojima M, Kangawa K, Nakao K (2000) Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 486:213–216PubMedCrossRef
18.
go back to reference Tena-sempere M, Barreiro ML, González LC, Gaytán F, Zhang FP, Caminos JE, Pinilla L, Casanueva FF, Diéguez C, Aguilar E (2002) Novel expression and functional role of ghrelin in rat testis. Endocrinology 143:717–725PubMedCrossRef Tena-sempere M, Barreiro ML, González LC, Gaytán F, Zhang FP, Caminos JE, Pinilla L, Casanueva FF, Diéguez C, Aguilar E (2002) Novel expression and functional role of ghrelin in rat testis. Endocrinology 143:717–725PubMedCrossRef
19.
go back to reference Lu S, Guan JL, Wang QP, Uehara K, Yamada S, Goto N, Date Y, Nakazato M, Kojima M, Kangawa K, Shioda S (2002) Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 321:157–160PubMedCrossRef Lu S, Guan JL, Wang QP, Uehara K, Yamada S, Goto N, Date Y, Nakazato M, Kojima M, Kangawa K, Shioda S (2002) Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 321:157–160PubMedCrossRef
20.
go back to reference Rotondo F, Cusimano M, Scheithauer BW, Rotondo A, Syro LV, Kovacs K (2011) Ghrelin immunoexpression in pituitary adenomas. Pituitary 14:318–322 Rotondo F, Cusimano M, Scheithauer BW, Rotondo A, Syro LV, Kovacs K (2011) Ghrelin immunoexpression in pituitary adenomas. Pituitary 14:318–322
21.
go back to reference Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992PubMedCrossRef Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992PubMedCrossRef
22.
go back to reference Cummings DE (2006) Ghrelin and the short-and long-term regulation of appetite and body weight. Physiol Behav 89:71–84PubMedCrossRef Cummings DE (2006) Ghrelin and the short-and long-term regulation of appetite and body weight. Physiol Behav 89:71–84PubMedCrossRef
23.
go back to reference Korbonits M, Kojima M, Kangawa K, Grossman AB (2001) Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 14:101–104PubMedCrossRef Korbonits M, Kojima M, Kangawa K, Grossman AB (2001) Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 14:101–104PubMedCrossRef
24.
go back to reference Janas-Kozik M, Krupa-Matuszczyk I, Tomasik-Krótki J (2006) Ghrelin- the guardian of energy balance. Psychiatr Pol 40:119–128PubMed Janas-Kozik M, Krupa-Matuszczyk I, Tomasik-Krótki J (2006) Ghrelin- the guardian of energy balance. Psychiatr Pol 40:119–128PubMed
25.
go back to reference Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J (2004) Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 144:36–42PubMedCrossRef Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J (2004) Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 144:36–42PubMedCrossRef
26.
go back to reference Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, Hosoda H, Kojima M, Kangawa K, Kohno N (2003) Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 9:774–778PubMed Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, Hosoda H, Kojima M, Kangawa K, Kohno N (2003) Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 9:774–778PubMed
27.
go back to reference Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M (2005) Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 90:2920–2926PubMedCrossRef Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M (2005) Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 90:2920–2926PubMedCrossRef
28.
go back to reference Nakahara T, Harada T, Yasuhara D, Shimada N, Amitani H, Sakoguchi T, Kamiji MM, Asakawa A, Inui A (2008) Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 64:252–255PubMedCrossRef Nakahara T, Harada T, Yasuhara D, Shimada N, Amitani H, Sakoguchi T, Kamiji MM, Asakawa A, Inui A (2008) Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 64:252–255PubMedCrossRef
29.
go back to reference Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, Aoyama T, Sakurada T, Takabayashi H, Hattori T (2010) Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology 151:3773–3782PubMedCrossRef Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, Aoyama T, Sakurada T, Takabayashi H, Hattori T (2010) Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology 151:3773–3782PubMedCrossRef
30.
go back to reference Scheithauer BW, Kovacs K, Jariwala LK, Randall RV, Ryan N (1988) Anorexia nervosa: an immunohistochemical study of the pituitary gland. Mayo Clin Proc 63:23–28PubMed Scheithauer BW, Kovacs K, Jariwala LK, Randall RV, Ryan N (1988) Anorexia nervosa: an immunohistochemical study of the pituitary gland. Mayo Clin Proc 63:23–28PubMed
31.
go back to reference Rotondo F, Scheithauer BW, Kovacs K, Bell DC (2009) Rab 3B immunoexpression in human pituitary adenomas. Appl Immunohistochem Mol Morphol 17:185–188PubMedCrossRef Rotondo F, Scheithauer BW, Kovacs K, Bell DC (2009) Rab 3B immunoexpression in human pituitary adenomas. Appl Immunohistochem Mol Morphol 17:185–188PubMedCrossRef
32.
go back to reference Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW (2006) Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol 111:272–277PubMedCrossRef Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW (2006) Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol 111:272–277PubMedCrossRef
33.
go back to reference Nakagawa SA, Lopes A, Lopes de Carvalho A, Rossi BM, Werneck da Cunha I, Soares FA, Chung WT, Alves LA (2010) Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine and angiogenesis in chondrosarcoma and their relation to prognosis. J Bone Joint Surg Am 92:1738–1746CrossRef Nakagawa SA, Lopes A, Lopes de Carvalho A, Rossi BM, Werneck da Cunha I, Soares FA, Chung WT, Alves LA (2010) Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine and angiogenesis in chondrosarcoma and their relation to prognosis. J Bone Joint Surg Am 92:1738–1746CrossRef
34.
go back to reference Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth-hormone releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255–4261PubMedCrossRef Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth-hormone releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255–4261PubMedCrossRef
35.
go back to reference Rindi G, Necchi V, Savio A, Torsello A, Zoli M, Locatelli V, Raimondo F, Cocchi D, Solcia E (2002) Characterization of gastric ghrelin cells in man and other mammals: studies in adults and fetal tissues. Histochem Cell Biol 117:511–519PubMedCrossRef Rindi G, Necchi V, Savio A, Torsello A, Zoli M, Locatelli V, Raimondo F, Cocchi D, Solcia E (2002) Characterization of gastric ghrelin cells in man and other mammals: studies in adults and fetal tissues. Histochem Cell Biol 117:511–519PubMedCrossRef
36.
go back to reference Rindi G, Torsello A, Locatelli V, Solcia E (2004) Ghrelin expression and actions: a novel peptide for an old cell type of the diffuse endocrine system. Exp Biol Med 229:1007–1016 Rindi G, Torsello A, Locatelli V, Solcia E (2004) Ghrelin expression and actions: a novel peptide for an old cell type of the diffuse endocrine system. Exp Biol Med 229:1007–1016
37.
go back to reference Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K (2001) Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280:R1483–R1487PubMed Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K (2001) Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280:R1483–R1487PubMed
38.
go back to reference Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S (2001) Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 280:904–907PubMedCrossRef Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S (2001) Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 280:904–907PubMedCrossRef
39.
go back to reference Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R, Ghigo E (2001) Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083–5086PubMedCrossRef Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R, Ghigo E (2001) Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083–5086PubMedCrossRef
40.
go back to reference Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K (2000) Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908–4911PubMedCrossRef Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K (2000) Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908–4911PubMedCrossRef
41.
go back to reference Shiiya T, Nakazato M, Mizuta M, Mondal SM, Nakazato M (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240–244PubMedCrossRef Shiiya T, Nakazato M, Mizuta M, Mondal SM, Nakazato M (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240–244PubMedCrossRef
42.
go back to reference Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K (2001) Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:227–232PubMedCrossRef Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K (2001) Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:227–232PubMedCrossRef
43.
go back to reference Kojima M, Hosoda H, Kangawa K (2004) Clinical endocrinology and metabolism. Ghrelin, a novel growth hormone-releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab 18:517–530PubMedCrossRef Kojima M, Hosoda H, Kangawa K (2004) Clinical endocrinology and metabolism. Ghrelin, a novel growth hormone-releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab 18:517–530PubMedCrossRef
44.
go back to reference Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan JL, Wang QP, Funahashi H, Sakurai T, Shioda S, Matsukura S, Kangawa K, Nakazato M (2003) Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144:1506–1512PubMedCrossRef Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan JL, Wang QP, Funahashi H, Sakurai T, Shioda S, Matsukura S, Kangawa K, Nakazato M (2003) Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144:1506–1512PubMedCrossRef
45.
go back to reference Funahashi H, Takenoya F, Guan JL, Kageyama H, Yada T, Shioda S (2003) Hypothalamic neuronal networks and feeding-related peptides involved in the regulation of feeding. Anat Sci Int 78:123–138PubMedCrossRef Funahashi H, Takenoya F, Guan JL, Kageyama H, Yada T, Shioda S (2003) Hypothalamic neuronal networks and feeding-related peptides involved in the regulation of feeding. Anat Sci Int 78:123–138PubMedCrossRef
46.
go back to reference Amar AP, Weiss MH (2003) Pituitary anatomy and physiology. Neurosurg Clin North Am 14:11–23CrossRef Amar AP, Weiss MH (2003) Pituitary anatomy and physiology. Neurosurg Clin North Am 14:11–23CrossRef
47.
go back to reference Takahashi K, Murakami O, Satoh F, Mouri T (2002) The hypothalamus and neurohypophysis. In: Stefaneanu L, Sasano H, Kovacs K (eds) Molecular and cellular endocrine pathology. Arnold, London, pp 45–74 Takahashi K, Murakami O, Satoh F, Mouri T (2002) The hypothalamus and neurohypophysis. In: Stefaneanu L, Sasano H, Kovacs K (eds) Molecular and cellular endocrine pathology. Arnold, London, pp 45–74
48.
go back to reference Mouri T, Itoi K, Takahashi K, Suda T, Murakami O, Yoshinaga K, Andoh N, Ohtani H, Masuda T, Sasano N (1993) Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 57:34–39PubMedCrossRef Mouri T, Itoi K, Takahashi K, Suda T, Murakami O, Yoshinaga K, Andoh N, Ohtani H, Masuda T, Sasano N (1993) Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 57:34–39PubMedCrossRef
49.
go back to reference Angelidis G, Valotassiou V, Georgoulias P (2010) Current and potential roles of ghrelin in clinical practice. J Endocrinol Invest 33:823–838PubMed Angelidis G, Valotassiou V, Georgoulias P (2010) Current and potential roles of ghrelin in clinical practice. J Endocrinol Invest 33:823–838PubMed
Metadata
Title
Pituitary immunoexpression of ghrelin in anorexia nervosa
Authors
Fabio Rotondo
Bernd W. Scheithauer
Luis V. Syro
Angelo Rotondo
Kalman Kovacs
Publication date
01-12-2012
Publisher
Springer US
Published in
Pituitary / Issue 4/2012
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0364-6

Other articles of this Issue 4/2012

Pituitary 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.